Concorde Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,745	Closed	-$205K	–	172
2021 Q3	$205K	Sell	2,745 -219	-7%	-$16.4K	0.12%	183
2021 Q2	$275K	Buy	2,964 +163	+6%	+$15.1K	0.15%	146
2021 Q1	$249K	Buy	+2,801	New	+$249K	0.14%	171